Viekira Pak Safety Alert Prompts Express Scripts Review Of Exclusive Coverage
This article was originally published in The Pink Sheet Daily
Executive Summary
Express Scripts has asked its pharmacy and therapeutics committee to review FDA's recent safety alert for AbbVie's hepatitis C drugs and will make a decision on any coverage changes after that.